-
-
-
-
-
-
-
Neurocrine Bio. (NBIX) PT Raised to $172 at Truist Securities
-
-
-
-
-
-
-
Neurocrine Biosciences Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Biotech sector Q1 earnings preview from RBC Capital Markets
-
-
-
-
-
-
-
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Tops Q1 EPS by 13c; reaffirms guidance
-
-
-
-
-
-
-
Neurocrine Biosciences Reports Third Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Tops Q4 EPS by 12c
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

